Skip to main
IPX

IperionX Ltd (IPX) Stock Forecast & Price Target

IperionX Ltd (IPX) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

IperionX Ltd is positioned favorably within the market due to its innovative titanium technologies that prioritize sustainability and low carbon intensity, aligning with growing industry demands for environmentally friendly materials. The company has recently seen an increase in its valuation with an uplift in the 2029 EBITDA multiple from 7x to 8x, reflecting continued progress in production and revenue growth. Additionally, IperionX's diverse holdings in critical minerals across its Titan Project in Tennessee bolster its long-term financial outlook, supporting sustained expansion and market relevance.

Bears say

IperionX Ltd faces various operational and technical risks inherent in the mining and industrial sectors, which could adversely impact its performance. Additionally, the company is exposed to commodity price risk, which may influence profitability and market competitiveness. Concerns regarding permitting or construction delays, production cost management, capital overruns, and potential dilution from financial transactions further contribute to a negative outlook on IperionX's stock.

IperionX Ltd (IPX) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IperionX Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IperionX Ltd (IPX) Forecast

Analysts have given IperionX Ltd (IPX) a Strong Buy based on their latest research and market trends.

According to 2 analysts, IperionX Ltd (IPX) has a Strong Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $51, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $51, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IperionX Ltd (IPX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.